Business ❯ Healthcare ❯ Pharmaceuticals

Oncology

Clinical Trials Drug Development Keytruda Pediatric Cancer Cancer Medicines Cisplatin-Induced Ototoxicity Sales Performance Gastrointestinal Cancers Guardant Health Collaboration Acute Leukaemia Cancer Immunotherapy Cancer Drugs Targeted Therapies Darzalex Data Collaboration Research and Development Johnson & Johnson Speciality Care Partnerships Precision Medicine Product Development Drug Sales Growth Antibody Drug Conjugates Cancer Pipeline Chronic Myeloid Leukaemia Antibody-Drug Conjugates CAR-T Therapies Drug Delivery Devices Lung Cancer Myelofibrosis Cancer Therapy Moderna

4 ARTICLES

3mo ago

Multiple Firms Vie to Lead Erasca Securities Suits After April Disclosures

A looming court deadline will decide who controls discovery into patent claims, preclinical comparisons and safety reports that investors say were concealed.

6 ARTICLES

3mo ago

Multiple Law Firms Seek Erasca Investors Ahead of August Lead‑Plaintiff Deadline

7 ARTICLES

3mo ago

Erasca Faces Securities Suit Over ERAS-0015 After Patent Claim and Trial Death Disclosures

7 ARTICLES

5mo ago

Pfizer and Innovent Strike Up to $10.5 Billion Oncology Collaboration

3 ARTICLES

6mo ago

Nuvation Bio Reports Q1 Growth as Iptrozy Moves Earlier in ROS1 Lung Cancer Care

8 ARTICLES

6mo ago

C-Further Launches First Pediatric Cancer Programs, Taps MiNK for PRAME iNKT Therapy

4 ARTICLES

9mo ago

Merck Lifts Mid-2030s Revenue Goal to $70 Billion From Emerging Businesses

10 ARTICLES

10mo ago

Merck Reportedly Weighs $28–$32 Billion Deal for Revolution Medicines After AbbVie Denial

6 ARTICLES

10mo ago

Amgen Buys Oxford Spinout Dark Blue Therapeutics for Up to $840 Million

8 ARTICLES

last yr.

J&J to Spin Off $9 Billion Orthopedics Unit as DePuy Synthes Within Two Years

5 ARTICLES

last yr.

Oncology

Multiple Firms Vie to Lead Erasca Securities Suits After April Disclosures

Multiple Law Firms Seek Erasca Investors Ahead of August Lead‑Plaintiff Deadline

Erasca Faces Securities Suit Over ERAS-0015 After Patent Claim and Trial Death Disclosures

Pfizer and Innovent Strike Up to $10.5 Billion Oncology Collaboration

Nuvation Bio Reports Q1 Growth as Iptrozy Moves Earlier in ROS1 Lung Cancer Care

Lilly’s Foundayo Start Trails Wegovy as Street Stays Positive

Gilead Expands Tempus Partnership for Enterprise Access to AI Oncology Platform

Gilead to Acquire Tubulis for Up to $5 Billion to Boost Cancer ADC Pipeline

Karyopharm Raises $30 Million in RA Capital Private Placement

C-Further Launches First Pediatric Cancer Programs, Taps MiNK for PRAME iNKT Therapy

Merck Lifts Mid-2030s Revenue Goal to $70 Billion From Emerging Businesses

Merck Reportedly Weighs $28–$32 Billion Deal for Revolution Medicines After AbbVie Denial

Amgen Buys Oxford Spinout Dark Blue Therapeutics for Up to $840 Million

J&J to Spin Off $9 Billion Orthopedics Unit as DePuy Synthes Within Two Years

Pfizer Lifts 2025 EPS Outlook, Targets $7.7 Billion in Savings as Dividend Draws Interest

Never miss stories about

Oncology